首页> 外文期刊>EFSA Journal >Scientific Opinion on the safety of the change in the production method of L‐glutamic acid (E620), monosodium L‐glutamate (E621), monopotassium L‐glutamate (E622), calcium di‐L‐glutamate (E623), monoammonium L‐glutamate (E624) and magnesium di‐L‐glutamate (E625)
【24h】

Scientific Opinion on the safety of the change in the production method of L‐glutamic acid (E620), monosodium L‐glutamate (E621), monopotassium L‐glutamate (E622), calcium di‐L‐glutamate (E623), monoammonium L‐glutamate (E624) and magnesium di‐L‐glutamate (E625)

机译:关于改变L-谷氨酸(E620),L-谷氨酸一钠(E621),L-谷氨酸一钾(E622),二L-谷氨酸钙(E623),L-一铵L-生产方法的安全性的科学意见谷氨酸(E624)和二-L-谷氨酸镁(E625)

获取原文
           

摘要

The Panel on Food Additives and Nutrient Sources added to Food (ANS) was asked to deliver a scientific opinion evaluating the safety of the change in the production method for the production of L‐glutamic acid (E620), monosodium ‐ L‐glutamate (E621), monopotassium L‐glutamate (E622), calcium di‐L‐glutamate (E623), monoammonium L‐glutamate (E624) and magnesium di‐L‐glutamate (E625). The L‐glutamic acid is produced by the genetically modified Corynebacterium glutamicum EA‐12 strain. The recipient strain Corynebacterium glutamicum strain2256 has been recommended for Qualified Presumption of Safety (QPS) status. No antibiotic resistance genes were left in the genome and neither the production strain nor its recombinant DNA were detected in the final product. The Panel considered there were no safety concerns for consumers from the genetic modification. The proposed uses or use levels of L‐glutamic acid and its salt derivatives produced with the current strain and the new genetically modified microorganism (GMM) strain will be identical and thus the Panel considered that the exposure to the food additive will remain unaffected. Provided that the L‐glutamic acid and its salts both produced with the current strain and with the GMM strain are equal in the specifications and physicochemical characteristics, the biological and toxicological data for the L‐glutamic acid and its salts produced with the current strain are considered by the Panel to support the safety of the food additives produced with the GMM strain. The Panel concluded that there are no safety concerns from the change in the production method of the food additives L‐glutamic acid (E620), monosodium L‐glutamate (E621), monopotassium L‐glutamate (E622), calcium di‐L‐glutamate (E623), monoammonium L‐glutamate (E624) and magnesium di‐L‐glutamate (E625) meeting their existing specifications.
机译:要求食品中添加的食品添加剂和营养来源委员会(ANS)提供科学意见,以评估生产L-谷氨酸(E620),L-谷氨酸一钠(E621)的生产方法变更的安全性),L-谷氨酸一钾(E622),L-谷氨酸二钙(E623),L-谷氨酸一铵(E624)和Di-L-谷氨酸镁(E625)。 L-谷氨酸是由转基因谷氨酸棒杆菌EA-12菌株产生的。已建议将受体菌株谷氨酸棒杆菌菌株2256列为合格安全性假定(QPS)状态。基因组中没有留下抗生素抗性基因,并且在最终产物中均未检测到生产菌株或其重组DNA。小组认为,转基因不会给消费者带来安全隐患。与当前菌株和新的转基因微生物(GMM)菌株生产的L-谷氨酸及其盐衍生物的拟议用途或使用水平将是相同的,因此,专家小组认为,暴露于食品添加剂的情况不会受到影响。假设当前菌株和GMM菌株生产的L-谷氨酸及其盐在规格和理化特性上均相同,则使用当前菌株生产的L-谷氨酸及其盐的生物学和毒理学数据为专家组认为可支持使用GMM菌株生产的食品添加剂的安全性。专家小组得出结论,改变食品添加剂L-谷氨酸(E620),L-谷氨酸一钠(E621),L-谷氨酸一钾(E622),二-L-谷氨酸钙的生产方法不存在安全隐患。 (E623),左旋谷氨酸单铵(E624)和二左旋谷氨酸镁(E625)符合现有规格。

著录项

  • 来源
    《EFSA Journal》 |2015年第1期|共20页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类 食品工业;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号